ELIMINATION OF ANTIPYRINE AND ITS METABOLITES IN INTERFERON-TREATED HEPATITIS-C

被引:4
|
作者
SIECK, JO
ELYAZIGI, A
ALI, H
DOSSING, M
SAOUR, J
RAINES, DA
ERNST, P
机构
[1] BISPEBJERG HOSP,DEPT MED P,DK-2400 COPENHAGEN,DENMARK
[2] KING FAISAL SPECIALIST HOSP & RES CTR,DEPT MED,RIYADH 11211,SAUDI ARABIA
[3] KING FAISAL SPECIALIST HOSP & RES CTR,DEPT BIOL & MED RES,RIYADH 11211,SAUDI ARABIA
[4] KING FAISAL SPECIALIST HOSP & RES CTR,DEPT ONCOL,RIYADH 11211,SAUDI ARABIA
来源
HUMAN & EXPERIMENTAL TOXICOLOGY | 1994年 / 13卷 / 09期
关键词
D O I
10.1177/096032719401300902
中图分类号
R99 [毒物学(毒理学)];
学科分类号
100405 ;
摘要
1 To study the effect of interferon on hepatic drug metabolism in chronic hepatitis C, we examined nine patients before and at the end of 6 months of interferon treatment. 2 Routine liver function was determined together with the salivary clearance of antipyrine and the 48 h urinary excretion of the main metabolites of antipyrine: 4-hydroxyantipyrine 3-hydroxymethylantipyrine and norantipyrine before and after 6 months of interferon treatment. 3 Liver pathology, routine liver function, and antipyrine metabolism remained unchanged after patients were treated for 6 months with interferon for a histologically advanced but clinically compensated chronic hepatitis C. ,
引用
收藏
页码:598 / 601
页数:4
相关论文
共 50 条
  • [41] QUANTITATIVE DETECTION OF HEPATITIS-C VIRUS (HCV) RNA BY SOLID-PHASE BRANCHED-CHAIN DNA AMPLIFICATION (BDNA) - APPLICATION IN INTERFERON-TREATED PATIENTS
    DAVIS, GL
    LAU, JYN
    URDEA, MS
    NEUWALD, P
    WILBER, JC
    ALBRECHT, J
    LINDSAY, K
    PERRILLO, RP
    HEPATOLOGY, 1992, 16 (04) : A200 - A200
  • [42] HEPATITIS-C VIRUS-RNA IN PLASMA AND BLOOD MONONUCLEAR-CELLS IN PATIENTS WITH CHRONIC HEPATITIS-C TREATED WITH ALPHA-INTERFERON
    OUNANIAN, A
    GUEDDAH, N
    ROLACHON, A
    THELU, MA
    ZARSKI, JP
    SEIGNEURIN, JM
    JOURNAL OF MEDICAL VIROLOGY, 1995, 45 (02) : 141 - 145
  • [43] GENOTYPES AND TITERS OF HEPATITIS-C VIRUS FOR PREDICTING RESPONSE TO INTERFERON IN PATIENTS WITH CHRONIC HEPATITIS-C
    HINO, K
    SAINOKAMI, S
    SHIMODA, K
    IINO, S
    WANG, Y
    OKAMOTO, H
    MIYAKAWA, Y
    MAYUMI, M
    JOURNAL OF MEDICAL VIROLOGY, 1994, 42 (03) : 299 - 305
  • [44] RELATIONSHIP BETWEEN ANTIVIRAL ACTIVITY CAUSED BY INTERFERON AND HEPATITIS-C VIRUS IN PATIENTS WITH HEPATITIS-C
    TAKEDA, T
    KUROKI, T
    MORIYOSHI, Y
    NISHIGUCHI, S
    NAKAJIMA, S
    SHIOMI, S
    KOBAYASHI, K
    GASTROENTEROLOGY, 1995, 108 (04) : A1181 - A1181
  • [45] Course of Graves Disease in Interferon-Treated Patients With Chronic Hepatitis C Virus Infection and in Uninfected Patients
    Minelli, Roberta
    Spagnoli, Francesca
    Marchesi, Elisabetta
    Venturi, Nicola
    Marina, Michela
    Orlandini, Alessandra
    Zardo, Marianna
    Ferrari, Carlo
    Ceresini, Graziano
    JOURNAL OF INVESTIGATIVE MEDICINE, 2013, 61 (08) : 1173 - 1177
  • [46] The viral clearance in interferon-treated chronic hepatitis C is associated with increased cytotoxic T cell frequencies
    Löhr, HF
    Schmitz, D
    Arenz, M
    Weyer, S
    Gerken, G
    zum Büschenfelde, KHM
    JOURNAL OF HEPATOLOGY, 1999, 31 (03) : 407 - 415
  • [47] TREATMENT OF CHRONIC REPLICATING HEPATITIS-C WITH INTERFERON
    VONWICHERT, P
    INTERNIST, 1993, 34 (09): : 875 - 876
  • [48] INTERFERON THERAPY OF CHRONIC HEPATITIS-C IN HEMOPHILIACS
    FRICKHOFEN, N
    ELLBRUCK, D
    SEIFRIED, E
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1995, 120 (05) : 157 - 157
  • [49] HEPATITIS-C SEROTYPE AND RESPONSE TO INTERFERON THERAPY
    CHEMELLO, L
    ALBERTI, A
    ROSE, K
    SIMMONDS, P
    NEW ENGLAND JOURNAL OF MEDICINE, 1994, 330 (02): : 143 - 143
  • [50] EFFECTS OF INTERFERON-ALPHA ON SERUM HEPATITIS-C VIRUS IN PATIENTS WITH CHRONIC HEPATITIS-C
    SHIBATA, M
    KUMADA, T
    YAMADA, M
    NAKANO, S
    KUDO, T
    MORISHIMA, T
    DIGESTIVE DISEASES AND SCIENCES, 1993, 38 (04) : 608 - 611